Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1987-06-08
1990-02-27
Moskowitz, Margaret
Drug, bio-affecting and body treating compositions
Lymphokine
435235, 435236, 435237, 435238, 435239, A61K 3912, C12N 700
Patent
active
049044680
ABSTRACT:
A vaccine for protecting canine animals from disease caused by infection with canine corona virus (CCV) which comprises an effective amount of the cell-associated CCV peplomer protein. A polyvalent vaccine comprising an effective amount of cell-associated CCV peplomer protein and an effective amount of an antigenic component which is protective against one or more additional pathogenic organisms or viruses are also disclosed.
REFERENCES:
patent: 4567042 (1986-01-01), Acree et al.
patent: 4567043 (1986-01-01), Acree et al.
Siddel et al., "The Structure and Replication of Corona Virus", Current Topics in Microbiology and Immunology 99:141 (1982).
Morein et al., Vaccine 3:83 (1985).
Delmas et al., J. Gen. Virol. 67, 1405-1418 (1986).
Jimenez et al., Journal of Virology, vol. 60, No. 1, Oct. 1986, pp. 131-139.
Niesters et al., Virus Res. 5: 253 (1986).
Gill Michael A.
May Stephen W.
Lentz Edward T.
Lourie Alan D.
Mohamed Abdel
Moskowitz Margaret
Norden Laboratories Inc.
LandOfFree
Canine coronavirus vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Canine coronavirus vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Canine coronavirus vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-172729